Kristy Kerchell Jones, | |
9403 Mansfield Rd, Shreveport, LA 71118-3815 | |
(318) 861-8938 | |
(844) 270-1958 |
Full Name | Kristy Kerchell Jones |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 9403 Mansfield Rd, Shreveport, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003323460 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kristy Kerchell Jones, 506 Highway 2, Sterlington, LA 71280-3004 Ph: (318) 598-5040 | Kristy Kerchell Jones, 9403 Mansfield Rd, Shreveport, LA 71118-3815 Ph: (318) 861-8938 |
News Archive
In a survey-based study of 21,889 adults in Canada, severe and/or frequent physical abuse during childhood and frequent childhood exposure to intimate partner violence were linked with higher risks or arthritis during adulthood arthritis, even after controlling for a range of factors. The findings are published in Arthritis Care & Research.
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
New research shows that a small minority of cancer cells in neuroendocrine tumours of the pancreas contribute to the overall growth and metastasis of the tumour. This discovery was made by a research group at Lund University, in collaboration with researchers at Karolinska Institutet, in Sweden.
A multidisciplinary research team led by Jonathan Lakey, Ph.D., professor of surgery and biomedical engineering at the University of California, Irvine, has developed a biomaterial for pancreatic islet transplants that doesn't trigger the body's immune response.
The first doses of Swine Flu have arrived in the United States, as health officials work quickly to inoculate people against the virus.
› Verified 8 days ago